Masatomo Nishikawa

About

Masatomo Nishikawa is a leading researcher in urologic oncology, with a focused expertise in robot-assisted radical prostatectomy (RARP) and its impact on patient outcomes. His work has significantly advanced the understanding of perioperative complications and recovery in prostate cancer surgery. Nishikawa’s most cited study (28 citations) investigates how different Trendelenburg positions during RARP affect intraocular pressure, a critical safety concern for prolonged surgeries. He also demonstrated that metabolic syndrome impairs early urinary continence recovery after RARP (13 citations), providing key insights for preoperative counseling. Additionally, his research confirmed the safety and feasibility of RARP in elderly Japanese patients (7 citations), helping to expand surgical candidacy for older populations. Through these contributions, Nishikawa has shaped clinical protocols that enhance surgical safety and postoperative quality of life. His work, grounded in prospective studies with substantial patient cohorts (over 300 cases), continues to influence urologic practice, particularly in optimizing robot-assisted techniques for diverse patient groups.

Research Focus

Key Achievements

Top Papers

1. 1
   Effects of 25- and 30-degree Trendelenburg positions on intraocular pressure changes during robot-assisted radical prostatectomy

   28 citations · 2017
2. 2
   Impact of metabolic syndrome on early recovery of continence after robot‐assisted radical prostatectomy

   13 citations · 2017
3. 3
   Safety and feasibility of robot-assisted radical prostatectomy for clinically localized prostate cancer in elderly Japanese patients

   7 citations · 2017

Key Collaborators

Contact & Links